Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- ChecktodayChange DetectedStandardized the India location spelling from Gūrgaon to Gurgaon (122001) for the recruitment site.SummaryDifference0.0%

- Check7 days agoChange DetectedGūrgaon, India, 122001 was added and Gurgaon, India, 122001 was removed. The revision tag was updated to v3.4.3.SummaryDifference0.0%

- Check14 days agoChange DetectedStandardized the site city name from Gūrgaon to Gurgaon for India, 122001 to ensure consistent spelling.SummaryDifference0.0%

- Check22 days agoChange DetectedA new research site was added in Columbus, Ohio (United States, 43214). The total number of locations increased from 263 to 264.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to core study content or user-facing information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded a site revision label v3.4.1; removed the funding-status notice and the earlier revision label v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.